1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cancer Genomic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Breast Cancer Genomic Testing 1.2.3 Lung Cancer Genomic Testing 1.2.4 Blood Cancer Genomic Testing 1.2.5 Liver Cancer Genomic Testing 1.2.6 Stomach Cancer Genomic Testing 1.2.7 Others 1.3 Market by Application 1.3.1 Global Cancer Genomic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Diagnostic Laboratories 1.3.5 Academic and Research Institutes 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cancer Genomic Testing Market Perspective (2017-2028) 2.2 Cancer Genomic Testing Growth Trends by Region 2.2.1 Cancer Genomic Testing Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Cancer Genomic Testing Historic Market Size by Region (2017-2022) 2.2.3 Cancer Genomic Testing Forecasted Market Size by Region (2023-2028) 2.3 Cancer Genomic Testing Market Dynamics 2.3.1 Cancer Genomic Testing Industry Trends 2.3.2 Cancer Genomic Testing Market Drivers 2.3.3 Cancer Genomic Testing Market Challenges 2.3.4 Cancer Genomic Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cancer Genomic Testing Players by Revenue 3.1.1 Global Top Cancer Genomic Testing Players by Revenue (2017-2022) 3.1.2 Global Cancer Genomic Testing Revenue Market Share by Players (2017-2022) 3.2 Global Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Cancer Genomic Testing Revenue 3.4 Global Cancer Genomic Testing Market Concentration Ratio 3.4.1 Global Cancer Genomic Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cancer Genomic Testing Revenue in 2021 3.5 Cancer Genomic Testing Key Players Head office and Area Served 3.6 Key Players Cancer Genomic Testing Product Solution and Service 3.7 Date of Enter into Cancer Genomic Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cancer Genomic Testing Breakdown Data by Type 4.1 Global Cancer Genomic Testing Historic Market Size by Type (2017-2022) 4.2 Global Cancer Genomic Testing Forecasted Market Size by Type (2023-2028) 5 Cancer Genomic Testing Breakdown Data by Application 5.1 Global Cancer Genomic Testing Historic Market Size by Application (2017-2022) 5.2 Global Cancer Genomic Testing Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Cancer Genomic Testing Market Size (2017-2028) 6.2 North America Cancer Genomic Testing Market Size by Type 6.2.1 North America Cancer Genomic Testing Market Size by Type (2017-2022) 6.2.2 North America Cancer Genomic Testing Market Size by Type (2023-2028) 6.2.3 North America Cancer Genomic Testing Market Share by Type (2017-2028) 6.3 North America Cancer Genomic Testing Market Size by Application 6.3.1 North America Cancer Genomic Testing Market Size by Application (2017-2022) 6.3.2 North America Cancer Genomic Testing Market Size by Application (2023-2028) 6.3.3 North America Cancer Genomic Testing Market Share by Application (2017-2028) 6.4 North America Cancer Genomic Testing Market Size by Country 6.4.1 North America Cancer Genomic Testing Market Size by Country (2017-2022) 6.4.2 North America Cancer Genomic Testing Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Cancer Genomic Testing Market Size (2017-2028) 7.2 Europe Cancer Genomic Testing Market Size by Type 7.2.1 Europe Cancer Genomic Testing Market Size by Type (2017-2022) 7.2.2 Europe Cancer Genomic Testing Market Size by Type (2023-2028) 7.2.3 Europe Cancer Genomic Testing Market Share by Type (2017-2028) 7.3 Europe Cancer Genomic Testing Market Size by Application 7.3.1 Europe Cancer Genomic Testing Market Size by Application (2017-2022) 7.3.2 Europe Cancer Genomic Testing Market Size by Application (2023-2028) 7.3.3 Europe Cancer Genomic Testing Market Share by Application (2017-2028) 7.4 Europe Cancer Genomic Testing Market Size by Country 7.4.1 Europe Cancer Genomic Testing Market Size by Country (2017-2022) 7.4.2 Europe Cancer Genomic Testing Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Cancer Genomic Testing Market Size (2017-2028) 8.2 Asia-Pacific Cancer Genomic Testing Market Size by Type 8.2.1 Asia-Pacific Cancer Genomic Testing Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Cancer Genomic Testing Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Cancer Genomic Testing Market Share by Type (2017-2028) 8.3 Asia-Pacific Cancer Genomic Testing Market Size by Application 8.3.1 Asia-Pacific Cancer Genomic Testing Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Cancer Genomic Testing Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Cancer Genomic Testing Market Share by Application (2017-2028) 8.4 Asia-Pacific Cancer Genomic Testing Market Size by Region 8.4.1 Asia-Pacific Cancer Genomic Testing Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Cancer Genomic Testing Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Cancer Genomic Testing Market Size (2017-2028) 9.2 Latin America Cancer Genomic Testing Market Size by Type 9.2.1 Latin America Cancer Genomic Testing Market Size by Type (2017-2022) 9.2.2 Latin America Cancer Genomic Testing Market Size by Type (2023-2028) 9.2.3 Latin America Cancer Genomic Testing Market Share by Type (2017-2028) 9.3 Latin America Cancer Genomic Testing Market Size by Application 9.3.1 Latin America Cancer Genomic Testing Market Size by Application (2017-2022) 9.3.2 Latin America Cancer Genomic Testing Market Size by Application (2023-2028) 9.3.3 Latin America Cancer Genomic Testing Market Share by Application (2017-2028) 9.4 Latin America Cancer Genomic Testing Market Size by Country 9.4.1 Latin America Cancer Genomic Testing Market Size by Country (2017-2022) 9.4.2 Latin America Cancer Genomic Testing Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cancer Genomic Testing Market Size (2017-2028) 10.2 Middle East & Africa Cancer Genomic Testing Market Size by Type 10.2.1 Middle East & Africa Cancer Genomic Testing Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Cancer Genomic Testing Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Cancer Genomic Testing Market Share by Type (2017-2028) 10.3 Middle East & Africa Cancer Genomic Testing Market Size by Application 10.3.1 Middle East & Africa Cancer Genomic Testing Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Cancer Genomic Testing Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Cancer Genomic Testing Market Share by Application (2017-2028) 10.4 Middle East & Africa Cancer Genomic Testing Market Size by Country 10.4.1 Middle East & Africa Cancer Genomic Testing Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Cancer Genomic Testing Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Myriad Genetics 11.1.1 Myriad Genetics Company Details 11.1.2 Myriad Genetics Business Overview 11.1.3 Myriad Genetics Cancer Genomic Testing Introduction 11.1.4 Myriad Genetics Revenue in Cancer Genomic Testing Business (2017-2022) 11.1.5 Myriad Genetics Recent Developments 11.2 Centogene AG 11.2.1 Centogene AG Company Details 11.2.2 Centogene AG Business Overview 11.2.3 Centogene AG Cancer Genomic Testing Introduction 11.2.4 Centogene AG Revenue in Cancer Genomic Testing Business (2017-2022) 11.2.5 Centogene AG Recent Developments 11.3 Color Genomics 11.3.1 Color Genomics Company Details 11.3.2 Color Genomics Business Overview 11.3.3 Color Genomics Cancer Genomic Testing Introduction 11.3.4 Color Genomics Revenue in Cancer Genomic Testing Business (2017-2022) 11.3.5 Color Genomics Recent Developments 11.4 Quest Diagnostics 11.4.1 Quest Diagnostics Company Details 11.4.2 Quest Diagnostics Business Overview 11.4.3 Quest Diagnostics Cancer Genomic Testing Introduction 11.4.4 Quest Diagnostics Revenue in Cancer Genomic Testing Business (2017-2022) 11.4.5 Quest Diagnostics Recent Developments 11.5 23andMe Inc. 11.5.1 23andMe Inc. Company Details 11.5.2 23andMe Inc. Business Overview 11.5.3 23andMe Inc. Cancer Genomic Testing Introduction 11.5.4 23andMe Inc. Revenue in Cancer Genomic Testing Business (2017-2022) 11.5.5 23andMe Inc. Recent Developments 11.6 Gene By Gene Ltd. 11.6.1 Gene By Gene Ltd. Company Details 11.6.2 Gene By Gene Ltd. Business Overview 11.6.3 Gene By Gene Ltd. Cancer Genomic Testing Introduction 11.6.4 Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2017-2022) 11.6.5 Gene By Gene Ltd. Recent Developments 11.7 LabCorp 11.7.1 LabCorp Company Details 11.7.2 LabCorp Business Overview 11.7.3 LabCorp Cancer Genomic Testing Introduction 11.7.4 LabCorp Revenue in Cancer Genomic Testing Business (2017-2022) 11.7.5 LabCorp Recent Developments 11.8 Positive Bioscience 11.8.1 Positive Bioscience Company Details 11.8.2 Positive Bioscience Business Overview 11.8.3 Positive Bioscience Cancer Genomic Testing Introduction 11.8.4 Positive Bioscience Revenue in Cancer Genomic Testing Business (2017-2022) 11.8.5 Positive Bioscience Recent Developments 11.9 Bio-Rad Laboratories 11.9.1 Bio-Rad Laboratories Company Details 11.9.2 Bio-Rad Laboratories Business Overview 11.9.3 Bio-Rad Laboratories Cancer Genomic Testing Introduction 11.9.4 Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2017-2022) 11.9.5 Bio-Rad Laboratories Recent Developments 11.10 Illumina, Inc. 11.10.1 Illumina, Inc. Company Details 11.10.2 Illumina, Inc. Business Overview 11.10.3 Illumina, Inc. Cancer Genomic Testing Introduction 11.10.4 Illumina, Inc. Revenue in Cancer Genomic Testing Business (2017-2022) 11.10.5 Illumina, Inc. Recent Developments 11.11 Agilent Technologies 11.11.1 Agilent Technologies Company Details 11.11.2 Agilent Technologies Business Overview 11.11.3 Agilent Technologies Cancer Genomic Testing Introduction 11.11.4 Agilent Technologies Revenue in Cancer Genomic Testing Business (2017-2022) 11.11.5 Agilent Technologies Recent Developments 11.12 Thermo Fisher Scientific 11.12.1 Thermo Fisher Scientific Company Details 11.12.2 Thermo Fisher Scientific Business Overview 11.12.3 Thermo Fisher Scientific Cancer Genomic Testing Introduction 11.12.4 Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2017-2022) 11.12.5 Thermo Fisher Scientific Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Cancer Genomic Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Breast Cancer Genomic Testing Table 3. Key Players of Lung Cancer Genomic Testing Table 4. Key Players of Blood Cancer Genomic Testing Table 5. Key Players of Liver Cancer Genomic Testing Table 6. Key Players of Stomach Cancer Genomic Testing Table 7. Key Players of Others Table 8. Global Cancer Genomic Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 9. Global Cancer Genomic Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 10. Global Cancer Genomic Testing Market Size by Region (2017-2022) & (US$ Million) Table 11. Global Cancer Genomic Testing Market Share by Region (2017-2022) Table 12. Global Cancer Genomic Testing Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 13. Global Cancer Genomic Testing Market Share by Region (2023-2028) Table 14. Cancer Genomic Testing Market Trends Table 15. Cancer Genomic Testing Market Drivers Table 16. Cancer Genomic Testing Market Challenges Table 17. Cancer Genomic Testing Market Restraints Table 18. Global Cancer Genomic Testing Revenue by Players (2017-2022) & (US$ Million) Table 19. Global Cancer Genomic Testing Revenue Share by Players (2017-2022) Table 20. Global Top Cancer Genomic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genomic Testing as of 2021) Table 21. Ranking of Global Top Cancer Genomic Testing Companies by Revenue (US$ Million) in 2021 Table 22. Global 5 Largest Players Market Share by Cancer Genomic Testing Revenue (CR5 and HHI) & (2017-2022) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Cancer Genomic Testing Product Solution and Service Table 25. Date of Enter into Cancer Genomic Testing Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Cancer Genomic Testing Market Size by Type (2017-2022) & (US$ Million) Table 28. Global Cancer Genomic Testing Revenue Market Share by Type (2017-2022) Table 29. Global Cancer Genomic Testing Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 30. Global Cancer Genomic Testing Revenue Market Share by Type (2023-2028) Table 31. Global Cancer Genomic Testing Market Size by Application (2017-2022) & (US$ Million) Table 32. Global Cancer Genomic Testing Revenue Share by Application (2017-2022) Table 33. Global Cancer Genomic Testing Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 34. Global Cancer Genomic Testing Revenue Share by Application (2023-2028) Table 35. North America Cancer Genomic Testing Market Size by Type (2017-2022) & (US$ Million) Table 36. North America Cancer Genomic Testing Market Size by Type (2023-2028) & (US$ Million) Table 37. North America Cancer Genomic Testing Market Size by Application (2017-2022) & (US$ Million) Table 38. North America Cancer Genomic Testing Market Size by Application (2023-2028) & (US$ Million) Table 39. North America Cancer Genomic Testing Market Size by Country (2017-2022) & (US$ Million) Table 40. North America Cancer Genomic Testing Market Size by Country (2023-2028) & (US$ Million) Table 41. Europe Cancer Genomic Testing Market Size by Type (2017-2022) & (US$ Million) Table 42. Europe Cancer Genomic Testing Market Size by Type (2023-2028) & (US$ Million) Table 43. Europe Cancer Genomic Testing Market Size by Application (2017-2022) & (US$ Million) Table 44. Europe Cancer Genomic Testing Market Size by Application (2023-2028) & (US$ Million) Table 45. Europe Cancer Genomic Testing Market Size by Country (2017-2022) & (US$ Million) Table 46. Europe Cancer Genomic Testing Market Size by Country (2023-2028) & (US$ Million) Table 47. Asia Pacific Cancer Genomic Testing Market Size by Type (2017-2022) & (US$ Million) Table 48. Asia Pacific Cancer Genomic Testing Market Size by Type (2023-2028) & (US$ Million) Table 49. Asia Pacific Cancer Genomic Testing Market Size by Application (2017-2022) & (US$ Million) Table 50. Asia Pacific Cancer Genomic Testing Market Size by Application (2023-2028) & (US$ Million) Table 51. Asia Pacific Cancer Genomic Testing Market Size by Region (2017-2022) & (US$ Million) Table 52. Asia Pacific Cancer Genomic Testing Market Size by Region (2023-2028) & (US$ Million) Table 53. Latin America Cancer Genomic Testing Market Size by Type (2017-2022) & (US$ Million) Table 54. Latin America Cancer Genomic Testing Market Size by Type (2023-2028) & (US$ Million) Table 55. Latin America Cancer Genomic Testing Market Size by Application (2017-2022) & (US$ Million) Table 56. Latin America Cancer Genomic Testing Market Size by Application (2023-2028) & (US$ Million) Table 57. Latin America Cancer Genomic Testing Market Size by Country (2017-2022) & (US$ Million) Table 58. Latin America Cancer Genomic Testing Market Size by Country (2023-2028) & (US$ Million) Table 59. Middle East and Africa Cancer Genomic Testing Market Size by Type (2017-2022) & (US$ Million) Table 60. Middle East and Africa Cancer Genomic Testing Market Size by Type (2023-2028) & (US$ Million) Table 61. Middle East and Africa Cancer Genomic Testing Market Size by Application (2017-2022) & (US$ Million) Table 62. Middle East and Africa Cancer Genomic Testing Market Size by Application (2023-2028) & (US$ Million) Table 63. Middle East and Africa Cancer Genomic Testing Market Size by Country (2017-2022) & (US$ Million) Table 64. Middle East and Africa Cancer Genomic Testing Market Size by Country (2023-2028) & (US$ Million) Table 65. Myriad Genetics Company Details Table 66. Myriad Genetics Business Overview Table 67. Myriad Genetics Cancer Genomic Testing Product Table 68. Myriad Genetics Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 69. Myriad Genetics Recent Developments Table 70. Centogene AG Company Details Table 71. Centogene AG Business Overview Table 72. Centogene AG Cancer Genomic Testing Product Table 73. Centogene AG Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 74. Centogene AG Recent Developments Table 75. Color Genomics Company Details Table 76. Color Genomics Business Overview Table 77. Color Genomics Cancer Genomic Testing Product Table 78. Color Genomics Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 79. Color Genomics Recent Developments Table 80. Quest Diagnostics Company Details Table 81. Quest Diagnostics Business Overview Table 82. Quest Diagnostics Cancer Genomic Testing Product Table 83. Quest Diagnostics Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 84. Quest Diagnostics Recent Developments Table 85. 23andMe Inc. Company Details Table 86. 23andMe Inc. Business Overview Table 87. 23andMe Inc. Cancer Genomic Testing Product Table 88. 23andMe Inc. Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 89. 23andMe Inc. Recent Developments Table 90. Gene By Gene Ltd. Company Details Table 91. Gene By Gene Ltd. Business Overview Table 92. Gene By Gene Ltd. Cancer Genomic Testing Product Table 93. Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 94. Gene By Gene Ltd. Recent Developments Table 95. LabCorp Company Details Table 96. LabCorp Business Overview Table 97. LabCorp Cancer Genomic Testing Product Table 98. LabCorp Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 99. LabCorp Recent Developments Table 100. Positive Bioscience Company Details Table 101. Positive Bioscience Business Overview Table 102. Positive Bioscience Cancer Genomic Testing Product Table 103. Positive Bioscience Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 104. Positive Bioscience Recent Developments Table 105. Bio-Rad Laboratories Company Details Table 106. Bio-Rad Laboratories Business Overview Table 107. Bio-Rad Laboratories Cancer Genomic Testing Product Table 108. Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 109. Bio-Rad Laboratories Recent Developments Table 110. Illumina, Inc. Company Details Table 111. Illumina, Inc. Business Overview Table 112. Illumina, Inc. Cancer Genomic Testing Product Table 113. Illumina, Inc. Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 114. Illumina, Inc. Recent Developments Table 115. Agilent Technologies Company Details Table 116. Agilent Technologies Business Overview Table 117. Agilent Technologies Cancer Genomic Testing Product Table 118. Agilent Technologies Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 119. Agilent Technologies Recent Developments Table 120. Thermo Fisher Scientific Company Details Table 121. Thermo Fisher Scientific Business Overview Table 122. Thermo Fisher Scientific Cancer Genomic Testing Product Table 123. Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 124. Thermo Fisher Scientific Recent Developments Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Genomic Testing Market Share by Type: 2021 VS 2028 Figure 2. Breast Cancer Genomic Testing Features Figure 3. Lung Cancer Genomic Testing Features Figure 4. Blood Cancer Genomic Testing Features Figure 5. Liver Cancer Genomic Testing Features Figure 6. Stomach Cancer Genomic Testing Features Figure 7. Others Features Figure 8. Global Cancer Genomic Testing Market Share by Application: 2021 VS 2028 Figure 9. Hospitals Case Studies Figure 10. Clinics Case Studies Figure 11. Diagnostic Laboratories Case Studies Figure 12. Academic and Research Institutes Case Studies Figure 13. Others Case Studies Figure 14. Cancer Genomic Testing Report Years Considered Figure 15. Global Cancer Genomic Testing Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 16. Global Cancer Genomic Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 17. Global Cancer Genomic Testing Market Share by Region: 2021 VS 2028 Figure 18. Global Cancer Genomic Testing Market Share by Players in 2021 Figure 19. Global Top Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genomic Testing as of 2021) Figure 20. The Top 10 and 5 Players Market Share by Cancer Genomic Testing Revenue in 2021 Figure 21. North America Cancer Genomic Testing Market Size YoY (2017-2028) & (US$ Million) Figure 22. North America Cancer Genomic Testing Market Size Market Share by Type (2017-2028) Figure 23. North America Cancer Genomic Testing Market Size Market Share by Application (2017-2028) Figure 24. North America Cancer Genomic Testing Market Size Share by Country (2017-2028) Figure 25. United States Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Canada Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Europe Cancer Genomic Testing Market Size YoY (2017-2028) & (US$ Million) Figure 28. Europe Cancer Genomic Testing Market Size Market Share by Type (2017-2028) Figure 29. Europe Cancer Genomic Testing Market Size Market Share by Application (2017-2028) Figure 30. Europe Cancer Genomic Testing Market Size Share by Country (2017-2028) Figure 31. Germany Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. France Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. U.K. Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Italy Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Russia Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Nordic Countries Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Asia-Pacific Cancer Genomic Testing Market Size YoY (2017-2028) & (US$ Million) Figure 38. Asia Pacific Cancer Genomic Testing Market Size Market Share by Type (2017-2028) Figure 39. Asia Pacific Cancer Genomic Testing Market Size Market Share by Application (2017-2028) Figure 40. Asia Pacific Cancer Genomic Testing Market Size Share by Region (2017-2028) Figure 41. China Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Japan Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. South Korea Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Southeast Asia Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. India Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Australia Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 47. Latin America Cancer Genomic Testing Market Size YoY (2017-2028) & (US$ Million) Figure 48. Latin America Cancer Genomic Testing Market Size Market Share by Type (2017-2028) Figure 49. Latin America Cancer Genomic Testing Market Size Market Share by Application (2017-2028) Figure 50. Latin America Cancer Genomic Testing Market Size Share by Country (2017-2028) Figure 51. Mexico Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. Brazil Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Middle East & Africa Cancer Genomic Testing Market Size YoY (2017-2028) & (US$ Million) Figure 54. Middle East and Africa Cancer Genomic Testing Market Size Market Share by Type (2017-2028) Figure 55. Middle East and Africa Cancer Genomic Testing Market Size Market Share by Application (2017-2028) Figure 56. Middle East and Africa Cancer Genomic Testing Market Size Share by Country (2017-2028) Figure 57. Turkey Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. Saudi Arabia Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 59. UAE Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 60. Myriad Genetics Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 61. Centogene AG Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 62. Color Genomics Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 63. Quest Diagnostics Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 64. 23andMe Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 65. Gene By Gene Ltd. Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 66. LabCorp Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 67. Positive Bioscience Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 68. Bio-Rad Laboratories Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 69. Illumina, Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 70. Agilent Technologies Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 71. Thermo Fisher Scientific Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

Myriad Genetics Centogene AG Color Genomics Quest Diagnostics 23andMe Inc. Gene By Gene Ltd. LabCorp Positive Bioscience Bio-Rad Laboratories Illumina, Inc. Agilent Technologies Thermo Fisher Scientific